Salix Pharmaceuticals Inc
USPTO Trademark & Patent Filings
Trademark applications and grants for Salix Pharmaceuticals Inc. Salix Pharmaceuticals Inc has 40 trademark applications. The latest application filed is for "EST. 2023 OPIOID-INDUCED CONSTIPATION AWARENESS DAY DECEMBER 5"
- Company Aliases
- Salix Pharmaceuticals, Inc.
- Salix Pharmaceuticals, Inc. - Bridgewater NJ US
Trademarks Patents
| Patent Application | Date |
|---|---|
| SOLID DISPERSION FORMS OF RIFAXIMIN 20220040157 - 17/468461 Golden; Pam ; et al. | 2022-02-10 |
| METHODS FOR TREATING IRRITABLE BOWEL SYNDROME (IBS) 20220031675 - 17/197561 Forbes; William ; et al. | 2022-02-03 |
| SOLID DISPERSION FORMS OF RIFAXIMIN 20210401813 - 17/468457 Golden; Pam ; et al. | 2021-12-30 |
| METHODS OF TREATING HEPATIC ENCEPHALOPATHY 20210275507 - 17/213678 Forbes; William | 2021-09-09 |
| SOLID DISPERSION FORMS OF RIFAXIMIN 20210205279 - 17/174829 Golden; Pam ; et al. | 2021-07-08 |
| NCAGE Code | 3NFH8 | SALIX PHARMACEUTICALS, INC. |
| CAGE Code | 3NFH8 | SALIX PHARMACEUTICALS, INC. |
| DUNS | 012775685 | Salix Pharmaceuticals, Inc. |
| SEC | 0001596858 | Salix Pharmaceuticals, Inc. of CALIFORNIA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 